<?xml version="1.0" encoding="UTF-8"?>
<p class="p">
 <italic class="italic">C. albicans</italic> infection is treated with antifungal agents [
 <xref rid="B14-antibiotics-08-00010" ref-type="bibr" class="xref">14</xref>]. Amphotericin B (AmB) is active against a broad range of pathogenes, including 
 <italic class="italic">Coccidioides immitis</italic>, 
 <italic class="italic">Candida</italic> species, 
 <italic class="italic">Rhodotorula</italic>, 
 <italic class="italic">Aspergillus fumigatus</italic>, etc. [
 <xref rid="B15-antibiotics-08-00010" ref-type="bibr" class="xref">15</xref>,
 <xref rid="B16-antibiotics-08-00010" ref-type="bibr" class="xref">16</xref>,
 <xref rid="B17-antibiotics-08-00010" ref-type="bibr" class="xref">17</xref>,
 <xref rid="B18-antibiotics-08-00010" ref-type="bibr" class="xref">18</xref>,
 <xref rid="B19-antibiotics-08-00010" ref-type="bibr" class="xref">19</xref>,
 <xref rid="B20-antibiotics-08-00010" ref-type="bibr" class="xref">20</xref>]. Although AmB medication is efficient in controlling the majority of 
 <italic class="italic">Candida</italic> infections, some limitations have been reported, such as drug resistance [
 <xref rid="B21-antibiotics-08-00010" ref-type="bibr" class="xref">21</xref>] and toxicity [
 <xref rid="B22-antibiotics-08-00010" ref-type="bibr" class="xref">22</xref>,
 <xref rid="B23-antibiotics-08-00010" ref-type="bibr" class="xref">23</xref>]. These limitations and changes in the spectrum of 
 <italic class="italic">Candida</italic> infections have generated enormous interest in developing new antifungal drugs using natural molecules such as plant essential oils (EOs). EOs reportedly play an important role in mediating plant defense mechanisms [
 <xref rid="B24-antibiotics-08-00010" ref-type="bibr" class="xref">24</xref>,
 <xref rid="B25-antibiotics-08-00010" ref-type="bibr" class="xref">25</xref>].
</p>
